XBI Holdings Information

XBI is an equity ETF with a total of 154 individual holdings. The top holdings are Apellis Pharmaceuticals stock at 1.87%, Revolution Medicines at 1.65%, Travere Therapeutics at 1.62%, Arrowhead Pharmaceuticals at 1.44%, and Twist Bioscience at 1.42%.

Total Holdings

154

Top 10 Percentage

14.84%

Asset Class

Equity

ETF Category

Health

Assets

8.22B

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	APLS	Apellis Pharmaceuticals, Inc.	1.87%	3,778,549
2	RVMD	Revolution Medicines, Inc.	1.65%	948,345
3	TVTX	Travere Therapeutics, Inc.	1.62%	3,191,708
4	ARWR	Arrowhead Pharmaceuticals, Inc.	1.44%	1,625,538
5	TWST	Twist Bioscience Corporation	1.42%	2,015,363
6	SMMT	Summit Therapeutics Inc.	1.40%	5,424,733
7	ALKS	Alkermes plc	1.38%	3,401,009
8	TGTX	TG Therapeutics, Inc.	1.37%	3,367,048
9	MDGL	Madrigal Pharmaceuticals, Inc.	1.36%	218,830
10	BEAM	Beam Therapeutics Inc.	1.32%	3,621,468
11	APGE	Apogee Therapeutics, Inc.	1.26%	1,264,718
12	SRRK	Scholar Rock Holding Corporation	1.23%	2,187,361
13	PRAX	Praxis Precision Medicines, Inc.	1.22%	318,014
14	EXEL	Exelixis, Inc.	1.21%	2,262,253
15	MIRM	Mirum Pharmaceuticals, Inc.	1.21%	1,029,446
16	UTHR	United Therapeutics Corporation	1.19%	173,369
17	NTRA	Natera, Inc.	1.19%	480,406
18	CELC	Celcuity Inc.	1.19%	815,946
19	CRSP	CRISPR Therapeutics AG	1.19%	1,891,634
20	KRYS	Krystal Biotech, Inc.	1.17%	370,357
21	PTGX	Protagonist Therapeutics, Inc.	1.17%	979,024
22	NBIX	Neurocrine Biosciences, Inc.	1.16%	729,133
23	INCY	Incyte Corporation	1.15%	997,827
24	CGON	CG Oncology, Inc.	1.15%	1,423,574
25	CYTK	Cytokinetics, Incorporated	1.14%	1,484,440

Showing 25 of 154 holdings

Subscribe to see the full list

Activate Now

As of Apr 30, 2026